InsidersTradesSigma
Track the Kiniksa Pharmaceuticals International, plc share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €9m. The latest transaction was filed on 21 August 2026 (Don). Among the most active insiders: Patel Sanj K. All data is free.
173
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€19m
20 ops.
Sell Volume
65Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,192 of 28,958 companies
21.3
score / 100
Value20
Quality22
FCF yld-6.2%
Earn yld-5.4%
EV/EBITDA·
ROE-9.9%
Gross mgn·
Net mgn-0.1%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 August 2026
Declarations173 total
2,600 shares0Class A Ordinary ShareSEC:0001384243-26-000014:0
403 sharesClass A Ordinary ShareSEC:0001454983-26-000008:0
4,500 shares0Class A Ordinary ShareSEC:0001337798-26-000004:1
3,673 shares@ US$81.433.18% mcap50.0% of flowClass A Ordinary ShareSEC:0001337798-26-000004:0
3,673 shares@ US$81.42993.18% mcap100.0% of flowClass A Ordinary ShareSEC144:0001921094-26-000767
67,062 shares@ US$79.737356.79% mcap70.9% of flowClass A Ordinary SharesSEC144:0001921094-26-000768
6,078 shares0Class A Ordinary SharesSEC:0001193125-26-253615:0
6,078 shares0Class A Ordinary SharesSEC:0001193125-26-253615:1
2,799 sharesClass A Ordinary ShareSEC:0001337798-26-000002:0
48,565 shares@ US$30.9315.49% mcap33.2% of flowClass A Ordinary ShareSEC:0001532218-26-000008:0
48,565 shares@ US$54.0227.05% mcap58.0% of flowClass A Ordinary ShareSEC:0001532218-26-000008:1
431,904 shares@ US$10.3646.19% mcap11.8% of flowClass A Ordinary ShareSEC:0001532218-26-000006:0
51,750 shares@ US$30.9316.52% mcap4.2% of flowClass A Ordinary ShareSEC:0001532218-26-000006:1
74,635 shares@ US$50.4338.85% mcap10.0% of flowClass A Ordinary ShareSEC:0001532218-26-000006:2
113,673 shares@ US$51.4760.39% mcap15.5% of flowClass A Ordinary ShareSEC:0001532218-26-000006:3
51,750 shares@ US$54.0228.86% mcap7.4% of flowClass A Ordinary ShareSEC:0001532218-26-000006:5
22,544 shares@ US$30.937.22% mcap1.9% of flowClass A Ordinary ShareSEC:0001532218-26-000006:6
22,544 shares@ US$54.0112.60% mcap3.2% of flowClass A Ordinary ShareSEC:0001532218-26-000006:7
2,141 shares@ US$30.930.68% mcap0.2% of flowClass A Ordinary ShareSEC:0001532218-26-000006:8
2,141 shares@ US$54.011.19% mcap0.3% of flowClass A Ordinary ShareSEC:0001532218-26-000006:9
243,596 shares@ €44.393933.5% of flowClass A Ordinary ShareSEC:0001532218-26-000006:4
13,099 shares@ US$14.331.94% mcap22.2% of flowClass A Ordinary ShareSEC:0001384243-26-000010:0
13,099 shares@ US$50.106.77% mcap77.8% of flowClass A Ordinary ShareSEC:0001384243-26-000010:1
6,625 shares@ US$46.6957.0% of flowClass A Ordinary ShareSEC:0001464583-26-000006:0
25 of 173 declarations
About Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals International, plc is a biopharmaceutical company focused on developing treatments for autoimmune and inflammatory diseases. It is listed on NASDAQ under the ticker KNSA.